DexCom, Inc. (DXCM)
73.43
-0.95
(-1.28%)
USD |
NASDAQ |
Feb 27, 16:00
73.42
-0.01
(-0.01%)
After-Hours: 20:00
DexCom Research and Development Expense (TTM) : 599.10M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| BioLife Solutions, Inc. | -- |
| Abbott Laboratories | 2.89B |
| Insulet Corp. | 301.10M |
| Krystal Biotech, Inc. | 55.08M |
| Boston Scientific Corp. | 2.052B |